Recent Quarter Total Invested
$669,000
Recent Quarter Institutional Ownership Percentage
6.11%
Total Invested of Last Quarter
$857,000
Ownership Percentage of Last Quarter
7.64%
Salarius Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/14/2022 | 1.35 M | $264,000 | -14.61% | 2.41% |
| RENAISSANCE TECHNOLOGIES LLC | 11/14/2022 | 634,261 | $124,000 | 17.88% | 1.13% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/14/2022 | 413,135 | $80,000 | 0.00% | 0.74% |
| TWO SIGMA ADVISERS, LP | 11/14/2022 | 310,000 | $60,000 | -4.97% | 0.55% |
| STATE STREET CORP | 11/15/2022 | 142,552 | $28,000 | 0.00% | 0.25% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2022 | 115,683 | $23,000 | -60.37% | 0.21% |
| X-SQUARE CAPITAL, LLC | 11/04/2022 | 89,000 | $17,000 | 0.00% | 0.16% |
| NORTHERN TRUST CORP | 11/14/2022 | 65,022 | $13,000 | 0.00% | 0.12% |
| HORIZON KINETICS ASSET MANAGEMENT LLC | 11/15/2022 | 60,000 | $12,000 | 50.00% | 0.11% |
| UBS GROUP AG | 11/10/2022 | 40,848 | $8,000 | -3.40% | 0.07% |
| WETHERBY ASSET MANAGEMENT INC | 11/14/2022 | 39,746 | $8,000 | 0.00% | 0.07% |
| BANK OF NEW YORK MELLON CORP | 11/14/2022 | 35,265 | $7,000 | 0.00% | 0.06% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2022 | 34,700 | $6,000 | -0.01% | 0.06% |
| ERN FINANCIAL, LLC | 11/14/2022 | 32,050 | $6,000 | 0.00% | 0.06% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/10/2022 | 24,089 | $5,000 | -69.59% | 0.04% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 10/17/2022 | 21,289 | $4,000 | 0.00% | 0.04% |
| TWO SIGMA SECURITIES, LLC | 11/14/2022 | 12,187 | $2,000 | -21.35% | 0.02% |
| LPL FINANCIAL LLC | 11/14/2022 | 10,023 | $2,000 | 0.00% | 0.02% |
| MORGAN STANLEY | 11/14/2022 | 1,502 | $0 | 0.13% | 0.00% |
| BLACKROCK INC. | 11/14/2022 | 1,197 | $0 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/14/2022 | 350 | $0 | -6.67% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 11/15/2022 | 0 | $0 | 0.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| HIGHTOWER ADVISORS, LLC | 11/09/2022 | 0 | $0 | -100.00% | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 11/16/2022 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 11/07/2022 | 0 | $0 | -100.00% | 0.00% |
| FINANCIAL ADVOCATES INVESTMENT MANAGEMENT | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
Salarius Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of SLRX shares?
During the previous two years, 2 institutional investors and hedge funds held shares of Salarius Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Advisor Group, Inc.: 1,900
LADENBURG THALMANN FINANCIAL SERVICES INC.: 4
-
What percentage of Salarius Pharmaceuticals, Inc. stock is owned by institutional investors?
6.11% of Salarius Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at SLRX ?
Institutional investors have bought a total of 1,904 shares in the last 24 months. This purchase volume represents approximately $2,704 in transactions.